| Baseline visit | Randomisation | study entry | 2, 4 months* | 6 months visit | 12 months visit | 18 months visit |
---|---|---|---|---|---|---|---|
Patient characteristics | X | Checking Inclusion & Exclusion Criteria | Â | Â | Â | Â | Â |
Gynaecologic examination | X | Â | Â | Â | Â | X | Â |
Assessment of pelvic floor functioning | X | Â | Â | Â | X | X | Â |
48 hour bladder diary | X | Â | Â | Â | X | X | Â |
Flow | X | Â | Â | Â | X | X | Â |
Residual volume | X | Â | Â | Â | X | X | Â |
Stress test | X | Â | Â | Â | X | X | Â |
Sandvik index | X | Â | Â | Â | X | X | Â |
24 hour pad test | X | Â | Â | Â | Â | X | Â |
Global Impression of severity | X | Â | Â | X | X | X | X |
Global Impression of improvement | Â | Â | Â | X | X | X | X |
EQ-5D | Â | Â | X | Â | X | X | X |
UDI | X | Â | Â | Â | X | X | X |
IIQ | X | Â | Â | Â | X | X | X |
Costs assessment* | Â | Â | X | X | X | X | X |
Compliance with treatment # | Â | Â | Â | X | Â | X | Â |
Complications of surgery# | Â | Â | Â | X | Â | Â | Â |